Guard Therapeutics Ownership

GUARD Stock  SEK 29.00  1.00  3.33%   
Guard Therapeutics secures a total of 503.08 Million outstanding shares. Guard Therapeutics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Some institutional investors establish a significant position in stocks such as Guard Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Guard Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guard Therapeutics International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

Guard Stock Ownership Analysis

About 30.0% of the company shares are held by company insiders. The book value of Guard Therapeutics was currently reported as 0.3. The company recorded a loss per share of 0.34. Guard Therapeutics had not issued any dividends in recent years. The entity had 50:1 split on the 15th of December 2023. Guard Therapeutics International AB , a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. Guard Therapeutics International AB was incorporated in 2008 and is based in Stockholm, Sweden. Guard Therapeutics is traded on Stockholm Stock Exchange in Sweden. To learn more about Guard Therapeutics International call Tobias Agervald at 46 86 70 65 51 or check out https://guardtherapeutics.com.

Pair Trading with Guard Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guard Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guard Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Guard Stock

  0.83SHB-B Svenska HandelsbankenPairCorr
  0.8SHB-A Svenska HandelsbankenPairCorr
  0.54ARION-SDB Arion banki hfPairCorr
  0.47SEB-C Skandinaviska Enskilda Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Guard Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guard Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guard Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guard Therapeutics International to buy it.
The correlation of Guard Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guard Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guard Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guard Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guard Therapeutics International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Guard Therapeutics information on this page should be used as a complementary analysis to other Guard Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Guard Stock analysis

When running Guard Therapeutics' price analysis, check to measure Guard Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guard Therapeutics is operating at the current time. Most of Guard Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guard Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guard Therapeutics' price. Additionally, you may evaluate how the addition of Guard Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Please note, there is a significant difference between Guard Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Guard Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guard Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.